期刊文献+

肿瘤坏死因子样凋亡的微弱诱导剂在类风湿关节炎成纤维样滑膜细胞的表达 被引量:2

The expression of TWEAKR/Fn14 in Rheumatoid arthritis fibroblast-like synoviocytes
下载PDF
导出
摘要 目的:通过对影响肿瘤坏死因子样凋亡的微弱诱导剂(TWEAKR/Fn14)在类风湿关节炎成纤维样滑膜细胞(RAFLS)表达因素的研究,探讨TWEAK诱导RAFLS活化及导致关节炎性破坏的相关机制。方法:将rhTWEAK与FLS共培养,同时加入TNF-α或IL-1β,应用免疫组化法定位检测TWEAKR/Fn14在RAFLS的表达,应用Western blot半定量检测TWEAKR/Fn14在RAFLS的表达。应用反转录-聚合酶链反应检测fn14基因mRNA的表达。结果:TWEAKR/Fn14表达在RAFLS的胞膜及胞质内,100μg/L的TWEAK增加TWEAKR/Fn14在RAFLS的表达及fn14mRNA的表达,TNF-α和IL-1β能够显著增强TWEAK对RAFLS的诱导作用。结论:RAFLS的质膜存在TWEAKR/Fn14表达,在重组TWEAK存在时TWEAKR/Fn14表达增加;TNF-α和IL-1β通过增加RAFLS的TWEAKR/Fn14表达,发挥对TWEAK生物学活性的协同作用。 AIM:To investigate the mechanism of TWEAK on Rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) activation and articular destruction by analyzing expression of TWEAKR/Fn14 on RA FLS. METHODS: FLS was co-cultured with rhTWEAK, with TNF-α or IL-1β as a synergistic stimulator. Expression of TWEAKR/Fn14 protein on RA FLS was detected by Immunocytochemistry and Western blotting. The fn14 mRNA was measured by RT-PCR. RESULTS: TWEAKR/Fn14 was expressed on the cell membrane and in the cytoplasm of RA FLS. TWEAKR/Fn14 mRNA and protein induced by 100 μg/L TWEAK were higher than the control group. TNF-α and IL-1β had synergistic effect on expression of TWEAKR/Fn14 in RA FLS. CONCLUSION: TWEAKR/Fn14 was expressed on the cell membrane and in the cytoplasm of RA FLS, and recombinant TWEAK further enhanced the TWEAKR/Fn14 expression. TNF-α and IL-1β had synergistic effect on the biological activity of TWEAK by increasing the expression of TWEAKR/Fn14 on RA FLS.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第6期575-577,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 辽宁省教育厅高等学校科学研究资金资助项目(202013141) 辽宁省自然科学基金资助项目(20042092)
关键词 TWEAKR/Fn14 成纤维样滑膜细胞 TWEAK TNF-Α IL-1Β TWEAKR/Fn14 fibroblasts-like synoviocyte TW-EAK TNF-α IL-1β
  • 相关文献

参考文献6

  • 1Kamata K, Kamijo S, Nakajima A, et al. Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis[J]. J lmmunol, 2006, 177(9):6433-6439.
  • 2夏丽萍,肖卫国,李俊松,丁爽,鲁静.TWEAK诱导类风湿关节炎成纤维样滑膜细胞合成MMP-3的实验研究[J].细胞与分子免疫学杂志,2009,25(1):46-48. 被引量:10
  • 3Brown SA, Richards CM, Hanscom HN, et al. The Fnl4 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1 2 3 and 5 and mediates nuclear factor-kappaB activation[ J]. Biochem J, 2003, 371 ( Pt 2) : 395 -403.
  • 4Nakayama M, Harada N, Okumura K, et al. Characterization of mufine TWEAK and its receptor (Fnl4) by monoelonal antibodies [J]. Biochem Biophys Res Commun, 2003, 306(4) : 819 -825.
  • 5Perper S J, Browning B, Burkly LC, et al. TWEAK is a novel arthritogenic mediator[J]. J lmmunol, 2006, 177(4) : 2610 -2620.
  • 6Meighan-Mantha RL, Hsu DK, Guo Y, et al. The milogen-indueible Fnl4 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration[J]. J Biol Chem, 1999, 274 (46) : 33166 - 33176.

二级参考文献9

  • 1Huber LC, Distler O, Tarner I, et al. Synovial fibroblasts; keyplayers in rheumatoid arthritis [ J ]. Rheurnatology ( Oxford), 2006, 45 ( 6 ) : 669 - 675.
  • 2Chicheportiche Y, Chicheportiche R, Sizing I, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies [J]. Arthritis Res, 2002, 4(2) : 126 -133.
  • 3Kamijo S, Nakajima A, Kamata K, et al. Involvement of TWEAK/ Fn14 interaction in the synovial inflammation of RA[ J]. Rheumatology (Oxford), 2008, 47(4): 442 -450.
  • 4Rannou F, Francois M, Corvol MT, et al. Cartilage breakdown in rheumatoid arthritis[J]. Joint Bone Spine, 2006, 73(1 ): 29-36.
  • 5Kamata K, Kamijo S, Nakajima A, et al. Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis[J]. J Immunol, 2006, 177(9):6433-6439.
  • 6Perper SJ, Browning B, Burkly LC, et al. TWEAK is a novel arthritogenic mediator [ J ]. J Immunol, 2006, 177 (4) : 2610 - 2620.
  • 7Nanki T. Molecular mechanisms of bone destruction in rheumatoid arthritis[J]. Clin Calcium, 2007, 17(4) : 510 -516.
  • 8Han S, Yoon K, Lee K, et al. TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors [ J ]. Biochem Biophys Res Commun, 2003, 305(4): 789-796.
  • 9Yepes M, Winkles JA. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases[ J]. Drug News Perspect, 2006 , 19(10) : 589 -595.

共引文献9

同被引文献35

  • 1张培培,王平,王国荣.中国药典2005年版(二部)主要变化[J].中国药品标准,2005,6(1):30-33. 被引量:3
  • 2陈柏松,徐玉东,钟淑琦,马彦文,马月秋.大鼠佐剂性关节炎模型的建立与评价[J].哈尔滨医科大学学报,2005,39(6):489-491. 被引量:50
  • 3姜旭淦,许化溪.信号转导途径在类风湿性关节炎治疗中的应用进展[J].医学综述,2006,12(8):456-459. 被引量:6
  • 4赵悦,王雪莲,刘沛.内毒素休克大鼠胸主动脉平滑肌细胞超微结构改变[J].中国医科大学学报,2006,35(1):3-4. 被引量:5
  • 5Hadi HA,Suwaidi JA.Endothelial dysfunction in diabetes mellitus[J] .Vasc Health Risk Manag,2007,3(6):853-876.
  • 6Kojima M,Hosoda H,Date Y,et al.Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J] .Nature,1999,402(6762):656-660.
  • 7Cao Y,Tang J,Yang T,et al.Cardioprotective effect of ghrelin in cardiopulmonary bypass involves a reduction in inflammatory response[J] .PLoS One,2013,8(1):e55021.
  • 8Deboer MD,Zhu X,Levasseur PR,et al.Ghrelin treatment of chronic kidney disease:improvements in lean body mass and cytokine profile[J] .Endocrinology,2008,149(2):827-835.
  • 9Hajmohammadi T,Sadeghi M,Dashti M,et al.Relationship between carotid intima-media thickness with some inflammatory biomarkers,ghrelin and adiponectin in iranians with and without metabolic syndrome in Isfahan cohort study[J] .ARYA Atheroscler,2010,6 (2):56-61.
  • 10Qi Q,Bray GA,Hu FB,et al.Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight,fasting glucose,and insulin resistance:the Preventing Overweight Using Novel Dietary Strategies trial[J] .Am J Clin Nutr,2012,95(2):506-513.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部